All Title Author
Keywords Abstract


Metagenomic biomarker discovery and explanation

DOI: 10.1186/gb-2011-12-6-r60

Full-Text   Cite this paper   Add to My Lib

Abstract:

Biomarker discovery has proven to be one of the most broadly applicable and successful means of translating molecular and genomic data into clinical practice. Comparisons between healthy and diseased tissues have highlighted the importance of tasks such as class discovery (detecting novel subtypes of a disease) and class prediction (determining the subtype of a new sample) [1-4], and recent metagenomic assays have shown that human microbial communities can be used as biomarkers for host factors such as lifestyle [5-7] and disease [7-10]. As sequencing technology continues to develop and makes microbial biomarkers increasingly easily detected, this enables clinical diagnostic and microbiological applications through the comparison of microbial communities [11,12].The human microbiome, consisting of the total microbial complement associated with human hosts, is an important emerging area for metagenomic biomarker discovery [13,14]. Changes in microbial abundances in the gut, oral cavity, and skin have been associated with disease states ranging from obesity [15-17] to psoriasis [18]. More generally, the metagenomic study of microbial communities is an effective approach for identifying the microorganisms or microbial metabolic characteristics of any uncultured sample [19,20]. Analyses of metagenomic data typically seek to identify the specific organisms, clades, operational taxonomic units, or pathways whose relative abundances differ between two or more groups of samples, and several features of microbial communities have been proposed as potential biomarkers for various disease states. For example, single pathogenic organisms can signal disease if present in a community [21,22], and increases and decreases in community complexity have been observed in bacterial vaginosis [23] and Crohn's disease [8]. Each of these different types of microbial biomarkers is correlated with disease phenotypes, but few bioinformatic methods exist to explain the class comparisons afford

Full-Text

comments powered by Disqus